Published in Cancer Weekly, October 9th, 2001
In these studies, it was observed that human liver tumors in mice could be completely eliminated following a single intravenous injection of CV890 combined with Doxorubicin.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.